The Board of Directors of Balaji Amines Limited (BAL) material subsidiary, Balaji Speciality Chemicals Limited (BSCL) has approved proposed initial public offering (IPO) of equity shares of face value of Rs. 2 each by the company's material subsidiary, Balaji Speciality Chemicals Limited.

The fund raising is subject to the receipt of requisite approvals including approval of the shareholders, market conditions and other considerations, by way of an initial public offer of its equity shares comprising of fresh issue of equity shares aggregating up to Rs. 250 crore (including share premium) and/or an offer of sale of equity shares by certain existing and eligible shareholders of the company, in accordance with the Companies Áct, 2013 and the rules made there under, the Securities and Exchange Board of India (lssue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws.

Balaji Amines Ltd. (BAL) specialised in manufacturing Methylamines, Ethylamines, Derivatives of Specialty Chemicals and Pharma Excipients. The company is one of the leading manufacturers of Aliphatic Amines in India and caters to the growing requirements of value based specialty chemicals. BAL commenced manufacture of Methyl Amines in the year 1989 and subsequently added facilities for manufacture of Ethyl Amines and other derivatives of Methyl Amines and Ethyl Amines.

BAL's manufacturing facility is located at Tamalwadi Village, near Solapur (Maharashtra State, India) The facility is fully equipped with latest technology like digital computerized controlled systems, which facilitates the control of operations from the control room in addition, BAL possesses an excellent R&D facilities and laboratory, which helps in conducting basic research and also to fine tune the process.